ConductScience.org, home

Paper37684152

Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine.

Good MF and 1 other. Trends Parasitol, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine. Papers, record 37684152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37684152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine.
PubMed
Journal
Trends Parasitol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2025-05-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Good MFMichael F
2Yanow SKStephanie K

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Malaria VaccinesMajor topic
EpitopesMajor topic
Vaccines, SubunitMajor topic
Humans
Malaria
Animals
Antigens, Protozoan
Plasmodium

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI150944NIAID NIH HHSUnited StatesR01AI150944PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133947856Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.Nat Commun2021https://conductscience.org/library/papers/33947856PubMed
236383682The RTS,S malaria vaccine: Current impact and foundation for the future.Sci Transl Med2022https://conductscience.org/library/papers/36383682PubMed
31928564Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.Am J Trop Med Hyg1991https://conductscience.org/library/papers/1928564PubMed
434355693The need for practical insecticide-resistance guidelines to effectively inform mosquito-borne disease control programs.Elife2021https://conductscience.org/library/papers/34355693PubMed
535835738Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.Nat Commun2022https://conductscience.org/library/papers/35835738PubMed
620098724The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.PLoS Med2010https://conductscience.org/library/papers/20098724PubMed
725075834Spread of artemisinin resistance in Plasmodium falciparum malaria.N Engl J Med2014https://conductscience.org/library/papers/25075834PubMed
811920300A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.J Infect Dis2002https://conductscience.org/library/papers/11920300PubMed
97520963Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.Lancet1994https://conductscience.org/library/papers/7520963PubMed
1033964223Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.Lancet2021https://conductscience.org/library/papers/33964223PubMed
1133854065Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses.NPJ Vaccines2021https://conductscience.org/library/papers/33854065PubMed
1224176554Escaping the immune system: How the malaria parasite makes vaccine development a challenge.Trends Parasitol2013https://conductscience.org/library/papers/24176554PubMed
1321916638A field trial to assess a blood-stage malaria vaccine.N Engl J Med2011https://conductscience.org/library/papers/21916638PubMed
1421916656Protection against malaria by MSP3 candidate vaccine.N Engl J Med2011https://conductscience.org/library/papers/21916656PubMed
1535130487Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults.Am J Trop Med Hyg2022https://conductscience.org/library/papers/35130487PubMed
1635103596A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.Elife2022https://conductscience.org/library/papers/35103596PubMed
1729736269Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy.NPJ Vaccines2018https://conductscience.org/library/papers/29736269PubMed
188958044Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci.Immunology1996https://conductscience.org/library/papers/8958044PubMed
1930630936High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.Mol Cell Proteomics2019https://conductscience.org/library/papers/30630936PubMed
2011226296The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11226296PubMed

See all 54 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
40900278
Designing a multi-epitope vaccine against the midgut-specific fibrinogen-related protein 1(FREP1) of Anopheles stephensi to enhance protection against the malaria parasite: a step beyond traditional vaccine development approaches.
Biotechnol Lett2025https://conductscience.org/library/papers/40900278PubMed
40234440Recent perspectives in clinical development of malaria vaccines.Nat Commun2025https://conductscience.org/library/papers/40234440PubMed
39921669Protection acquired upon intraperitoneal group a Streptococcus immunization is independent of concurrent adaptive immune responses but relies on macrophages and IFN-γ.Virulence2025https://conductscience.org/library/papers/39921669PubMed
38842304Detection of naturally acquired, strain-transcending antibodies against rosetting Plasmodium falciparum strains in humans.Infect Immun2024https://conductscience.org/library/papers/38842304PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37684152

GET https://conductscience.org/api/papers/v1/37684152/references?page=2